{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:23:42Z","timestamp":1790205822755,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.resp.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T19:45:27Z","timestamp":1393357527000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"196","author":[{"given":"Donald A.","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Kupchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2014.02.008_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(86)91514-3","article-title":"Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system","volume":"399","author":"Arai","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.resp.2014.02.008_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-1759(92)90062-X","article-title":"Amplification systems in immunoenzymatic techniques","volume":"150","author":"Avrameas","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.resp.2014.02.008_bib0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/ajrccm\/142.4.812","article-title":"Endogenous opioids modulate the increase in ventilatory output and dyspnea during severe acute bronchoconstriction","volume":"142","author":"Bellofiore","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.resp.2014.02.008_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0034-5687(95)00045-F","article-title":"Neurotransmitters in the CNS control of breathing","volume":"101","author":"Bonham","year":"1995","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.resp.2014.02.008_bib0025","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2165\/11203680-000000000-00000","article-title":"Aprepitant: a review of its use in the prevention of nausea and vomiting","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.resp.2014.02.008_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2005.12.066","article-title":"Extending the understanding of sensory neuropeptides","volume":"533","author":"De Swert","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2014.02.008_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.resp.2008.06.007","article-title":"Neuromodulation and the orchestration of the respiratory rhythm","volume":"164","author":"Doi","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.resp.2014.02.008_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(88)90771-8","article-title":"Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat","volume":"451","author":"Duggan","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.resp.2014.02.008_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","article-title":"The role of substance P in stress and anxiety responses","volume":"31","author":"Ebner","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.resp.2014.02.008_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1378\/chest.63.2.136","article-title":"Attachment for automated single breath diffusing capacity measurement","volume":"63","author":"Gaensler","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.resp.2014.02.008_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15412555.2011.560132","article-title":"Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD","volume":"8","author":"Gifford","year":"2011","journal-title":"COPD"},{"key":"10.1016\/j.resp.2014.02.008_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl. 11","key":"10.1016\/j.resp.2014.02.008_bib0065","first-page":"18","article-title":"Imaging substance P receptors (NK1) in the living human brain using positron emission tomography","volume":"63","author":"Hargreaves","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.resp.2014.02.008_bib0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1476-5381.1997.tb06829.x","article-title":"The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues","volume":"120","author":"Hughes","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.resp.2014.02.008_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/jappl.1989.66.1.161","article-title":"Hypothalamic-pituitary-adrenal responses to short-duration high-intensity cycle exercise","volume":"66","author":"Kraemer","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.resp.2014.02.008_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(93)90927-A","article-title":"Tachykinin-mediated respiratory effects in conscious guinea pigs: modulation by NK1 and NK2 receptor antagonists","volume":"241","author":"Kudlacz","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2014.02.008_bib0085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2014.02.008_bib0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1183\/09031936.00145208","article-title":"Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD","volume":"33","author":"Mahler","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2014.02.008_bib0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.07-0703","article-title":"Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes","volume":"132","author":"Mahler","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resp.2014.02.008_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(84)90470-0","article-title":"Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand","volume":"307","author":"Mantyh","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.resp.2014.02.008_bib0105","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1378\/chest.11-1087","article-title":"Reliability and validity of the multidimensional dyspnea profile","volume":"141","author":"Meek","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.resp.2014.02.008_bib0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0896-6273(03)00092-8","article-title":"Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation","volume":"37","author":"Mellen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.resp.2014.02.008_bib0115","doi-asserted-by":"crossref","unstructured":"Parshall, M.B., Schwartzstein, R.M., Adams, L., Banzett, R.B., Manning, H.L., Bourbeau, J., Calverley, P.M., Gift, A.G., Harver, A., Lareau, S.C., Mahler, D.A., Meek, P.M., O\u2018Donnell, D.E., on behalf of the ATS Committee on Dyspnea, 2012. An Official American Thoracic Society Statement: update on the mechanisms, assessment, and management of dyspnea. Am. J. Respir. Crit. Care Med. 185, 435\u2013452.","DOI":"10.1164\/rccm.201111-2042ST"},{"key":"10.1016\/j.resp.2014.02.008_bib0120","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.200507-1037OC","article-title":"Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease","volume":"172","author":"Pepin","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2014.02.008_bib0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","article-title":"Enzyme immunoassay techniques. An overview","volume":"150","author":"Porstmann","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.resp.2014.02.008_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4179(98)90015-4","article-title":"The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles","volume":"32","author":"Quartara","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.resp.2014.02.008_bib0135","doi-asserted-by":"crossref","unstructured":"Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., Zielinski, J., Global Initiative for Chronic Obstructive Lung Disease, 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532\u2013555.","DOI":"10.1164\/rccm.200703-456SO"},{"key":"10.1016\/j.resp.2014.02.008_bib0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1054\/npep.2000.0834","article-title":"Neuroanatomical localisation of Substance P in the CNS and sensory neurons","volume":"34","author":"Ribeiro-da-Silva","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.resp.2014.02.008_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0006-8993(90)90830-5","article-title":"Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes","volume":"529","author":"Schaible","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.resp.2014.02.008_bib0150","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1152\/jappl.1991.71.6.2077","article-title":"Sensory neuropeptides and airway function","volume":"71","author":"Solway","year":"1991","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.resp.2014.02.008_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","article-title":"Peripheral mechanisms of opioid analgesia","volume":"9","author":"Stein","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.resp.2014.02.008_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1164\/ajrccm\/151.3_Pt_1.613","article-title":"Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis","volume":"151","author":"Tomaki","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2014.02.008_bib0165","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0024-3205(00)00434-3","article-title":"Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea","volume":"66","author":"Zebraski","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.resp.2014.02.008_bib0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904814000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904814000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:32:17Z","timestamp":1761604337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904814000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":34,"alternative-id":["S1569904814000494"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2014.02.008","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}